Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001382563 | SCV001581403 | pathogenic | Carnitine palmitoyl transferase 1A deficiency | 2022-12-31 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1070426). This premature translational stop signal has been observed in individual(s) with a positive newborn screening result for CPT1A-related disease (PMID: 29519241). This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Arg339*) in the CPT1A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CPT1A are known to be pathogenic (PMID: 16169268). |
Baylor Genetics | RCV001382563 | SCV004211006 | pathogenic | Carnitine palmitoyl transferase 1A deficiency | 2023-03-27 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001382563 | SCV002092960 | pathogenic | Carnitine palmitoyl transferase 1A deficiency | 2020-09-15 | no assertion criteria provided | clinical testing |